Adenotonsillar hypertrophy-induced obstructive sleep apnea presenting as severe pulmonary hypertension and right heart failure in a child
Annals of Pediatric Cardiology · 2026-11 · 19 (6) · 791-796
DOI: 10.4103/apc.apc_133_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pediatric Cardiology, online erschienen am 16.11.2026. Verfasst von Munesh Tomar und 4 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Obstructive sleep apnea (OSA) affects approximately 2%–3% of the pediatric population, with adenotonsillar hypertrophy (ATH) recognized as the predominant anatomical etiology, especially in otherwise healthy children. While ATH-induced OSA is common, its progression to pulmonary hypertension (PH, World Health Organization Group III) and right heart failure is rare (
Zitieren
APA
Tomar, M., Jain, P., Gupta, R., Chaudhuri, M., & Jain, N. (2026). Adenotonsillar hypertrophy-induced obstructive sleep apnea presenting as severe pulmonary hypertension and right heart failure in a child. Annals of Pediatric Cardiology, 19(6), 791-796. https://doi.org/10.4103/apc.apc_133_26
Vancouver
Tomar M, Jain P, Gupta R, Chaudhuri M, Jain N. Adenotonsillar hypertrophy-induced obstructive sleep apnea presenting as severe pulmonary hypertension and right heart failure in a child. Annals of Pediatric Cardiology. 2026;19(6):791-796. doi:10.4103/apc.apc_133_26
BibTeX
@article{Tomar2026,
author = {Tomar, Munesh and Jain, Pragati and Gupta, Rishabh and Chaudhuri, Maitri and Jain, Nikunj},
title = {Adenotonsillar hypertrophy-induced obstructive sleep apnea presenting as severe pulmonary hypertension and right heart failure in a child},
journal = {Annals of Pediatric Cardiology},
year = {2026},
volume = {19},
number = {6},
pages = {791--796},
doi = {10.4103/apc.apc_133_26}
}
EUVIMED